The identification of sema3B and sema3F as tumor suppressors [13], [14], [38], and the identification of sema3F and sema3A as inhibitors of angiogenesis [15], [39], suggested that additional sema3s may also possess anti-tumorigenic and anti-angiogenic properties. Here, SEMA3A is linked to neoplasm.